Securing access to vaccines

Safe and effective vaccines against COVID-19 are the best way out of the pandemic. The Commission and Member States have taken a common EU approach to securing supplies and facilitating their distribution.

Through Advance Purchase Agreements with individual vaccine producers, the Commission secured the right to buy a specified number of vaccine doses in a given timeframe and at a given price. In return, the Commission financed a part of the upfront costs from the €2.7 billion Emergency Support Instrument. This funding was considered a down-payment on the vaccines that Member States purchase.

Objectives of the strategy

On 17 June 2020, the European Commission presented the EU Vaccines Strategy to accelerate the development, manufacturing and deployment of vaccines against COVID-19.

With the vaccines strategy, the Commission supported efforts to make the process more efficient, resulting in this timeframe being reduced to less than one year for most vaccines.

The objectives of the EU Vaccines Strategy are:

  • to ensue the quality, safety and efficacy of vaccines
  • to secure timely access to vaccines for Member States and their population while leading the global solidarity effort
  • to ensure equitable and affordable access for all in the EU to an affordable vaccine as early as possible
  • to make sure that preparations are made in EU countries regarding the roll-out of safe and effective vaccines, addressing transportation and deployment needs, and identifying priority groups 

The vaccine strategy should act as a reference point for Member States when formulating their national vaccination strategies.

Safe and effective vaccines started to be distributed in the EU by the end of 2020, following strict authorisation procedures and the highest safety standards.

Authorised Vaccines

To date, 4 safe and effective vaccines against COVID-19 have been authorised by the Commission for use in the EU following positive scientific recommendations by the European Medicines Agency

Documents

Redacted Advance Purchase Agreements

DownloadPDF - 13.7 MB
DownloadPDF - 26.9 MB
DownloadPDF - 4.9 MB
DownloadPDF - 3 MB
DownloadPDF - 815 KB
DownloadPDF - 18.6 MB
DownloadPDF - 5.3 MB
DownloadPDF - 11.3 MB
DownloadPDF - 6.6 MB

Legislative documents

DownloadPDF - 244.3 KB
DownloadPDF - 247.4 KB
DownloadPDF - 326.7 KB

Factsheets

Public opinion on COVID-19 vaccination

DownloadPDF - 3.2 MB